Evidence map›Paper›PMID 29748329›Full record

ArticleJournal of the American Society of Nephrology : JASN2018

Oral Antibiotic Exposure and Kidney Stone Disease.

Gregory E Tasian, Thomas Jemielita, David S Goldfarb, Lawrence Copelovitch, Jeffrey S Gerber, Qufei Wu, Michelle R Denburg

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed, 1 pooled it
13.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 1 synthesis or guideline pooled it, 139 citations in OpenAlex.

  1. Pooled it
  2. Urolithiasis in patients with cancer.Nature reviews. Urology · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. How is the human microbiome linked to kidney stones?Frontiers in cellular and infection microbiology · 2025
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Effects of Medications on theKidney international reports · 2024
    Article
  18. Article
  19. Article
  20. Review

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Gregory E TasianDivision of Pediatric Urology, Department of Surgery, and tasiang@chop.edu.
Thomas JemielitaBiostatistics and Research Decision Science, Early Oncology Department, Merck & Co., Inc., North Wales, Pennsylvania.
David S GoldfarbDivision of Nephrology, Department of Medicine, New York University Langone Medical Center, New York, New York; and Divisions of.
Lawrence CopelovitchNephrology and.
Jeffrey S GerberCenter for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Qufei WuDepartment of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Michelle R DenburgCenter for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Pediatric Nephrology of Alabama · USUniversity of Pennsylvania · USChildren's Hospital of Philadelphia · USMerck & Co., Inc., Rahway, NJ, USA (United States) · USNYU Langone Health · US

Funding

Primary HyperoxaluriaU54DK083908 · NIDDK · MAYO CLINIC ROCHESTER · PI MILLINER, DAWN SCHMAUTZ · 2009 to 2018
$12.3M
Vitamin D Deficiency in Glomerular DiseaseK23DK093556 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI DENBURG, MICHELLE · 2012 to 2016
$858k
Identifying and Mitigating Risk Factors for Dehydration-Mediated Nephrolithiasis in AdolescentsK23DK106428 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI TASIAN, GREGORY EDWARD · 2015 to 2019
$836k
NIDDK NIH HHS K23 DK093556NIDDK NIH HHS K23 DK106428NIDDK NIH HHS U54 DK083908
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Administration, OralAdultAge FactorsAnti-Bacterial AgentsCase-Control StudiesCephalosporinsFemaleFluoroquinolonesHumansIncidenceKidney CalculiMaleMethenamineMiddle AgedNitrofurantoinPenicillinsAnti-Bacterial AgentsCephalosporinsFluoroquinolonesMethenamineNitrofurantoinPenicillinsantibiotickidney stonesmicrobiome

Identifiers

PMID29748329
PMCPMC6054354
OpenAlexW2799399481

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.